Vigil Neuroscience, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
VIGL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
100 Forge Road, Suite 700, Watertown, MA

Insiders trading volume in the past year

Vigil Neuroscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bruce Booth Director $22M Jun 5, 2024
Atlas Venture Fund XII, L.P. 10%+ Owner $21.9M Jan 11, 2022
Stefan Vitorovic Director $18.9M Jun 5, 2024
Vida Ventures GP III, L.L.C. 10%+ Owner $18.8M Jan 11, 2022
Northpond Ventures GP, LLC 10%+ Owner $15.8M Jan 11, 2022
Amgen Inc 10%+ Owner $12M Jan 11, 2022
Clay Thorp Director $5.85M May 16, 2022
Ivana Magovcevic-Liebisch President and CEO, Director $3.19M +$28.5K +0.9% Dec 19, 2024
Cormorant Asset Management, LP Former 10% Owner $2.31M Jan 11, 2022
L. Gray David Chief Science Officer $2.03M May 3, 2024
Jennifer Lynn Ziolkowski Chief Financial Officer $1.03M May 3, 2024
Alexandria Venture Investments, LLC 10%+ Owner $724K Jan 11, 2022
Christopher Verni General Counsel $648K May 3, 2024
Samantha Budd Haeberlein Director $158K +$20.5K +14.9% Dec 19, 2024
Mary Thistle Director $138K Jun 5, 2024
Cheryl R. Blanchard Director $138K Jun 5, 2024
Suzanne Louise Bruhn Director $138K Jun 5, 2024
Gerhard Koenig Director $138K Jun 5, 2024
Spyros Papapetropoulos Chief Medical Officer $15K Nov 18, 2022
Christopher Silber Chief Medical Officer Aug 7, 2023
Evan Thackaberry SVP, Head of Early Development Mar 1, 2023
Petra Kaufmann Chief Medical Officer Mar 18, 2024
Shaan-Chirag C. Gandhi Director Jan 6, 2022

Recent Insider Transactions by Companies or Individuals for Vigil Neuroscience, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.